青光眼引流管手术后慢性低眼压:三项随机临床试验数据的汇总分析
汇总3项多中心随机临床试验共621例药物无法控制青光眼患者,比较Ahmed阀与Baerveldt植入物术后慢性低眼压(眼压≤5 mm Hg连续2次、术后3个月后、结扎或取出植入物)的发生率和危险因素。5年累积发生率为4.1%(95% CI=2.6%-6.1%),15例(71%)诊断时视力较基线下降。多变量分析显示Baerveldt植入物(HR=5.12)、葡萄膜炎性青光眼(HR=3.75)和术前视力差(每logMAR单位HR=1.55)是显著预测因素。
要点
- 引流管手术后5年慢性低眼压累积概率为4.1%(95% CI=2.6%-6.1%)。
- Baerveldt植入物、葡萄膜炎性青光眼和术前视力差与慢性低眼压显著相关。
- 慢性低眼压诊断时71%(15例)患者视力较基线下降。
核心结论
- 慢性低眼压是引流管手术不常见的并发症,通常导致视力下降。
- 与慢性低眼压相关的基线因素包括Baerveldt植入物、葡萄膜炎性青光眼和视力差。
研究设计与样本
- 汇总分析3项独立、多中心随机临床试验,共621例药物无法控制的青光眼患者:Ahmed Baerveldt比较研究276例、Ahmed对比Baerveldt研究238例、小梁切除术对比引流管研究引流管组107例。
- 患者随机接受Ahmed青光眼阀(FP7型)或Baerveldt青光眼植入物(101-350型)植入。
- 以患者为单位收集基线和随访数据并汇总,采用Cox比例风险回归模型分析基线危险因素与慢性低眼压的关联。
主要发现
- 引流管手术后5年慢性低眼压累积概率为4.1%(95% CI=2.6%-6.1%)。
- 诊断慢性低眼压时,15例(71%)患者视力较基线下降。
- 多变量分析中,随机接受Baerveldt植入物者发生慢性低眼压的风险为接受Ahmed阀者的5.12倍(HR=5.12;95% CI=1.51-17.43;P=.009)。
- 葡萄膜炎性青光眼患者发生慢性低眼压的风险为无该因素者的3.75倍(HR=3.75;95% CI=1.26-11.15;P=.017)。
- 术前视力每增加1个logMAR单位,慢性低眼压风险增加55%(HR=1.55;95% CI=1.04-2.32;P=.031)。
关键数值与推荐
- 慢性低眼压定义为术后3个月后连续2次随访眼压≤5 mm Hg,或因低眼压行引流管结扎或植入物取出。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the incidence and risk factors for chronic hypotony following tube shunt surgery. DESIGN: Pooled analysis of 3 independent, multicenter randomized clinical trials. PARTICIPANTS: A total of 621 patients with medically uncontrolled glaucoma, including 276 from the Ahmed Baerveldt Comparison Study, 238 from the Ahmed Versus Baerveldt Study, and 107 from the tube group of the Tube Versus Trabeculectomy Study. METHODS: Enrolled patients had been randomized to placement of either an Ahmed glaucoma valve (model FP7) or a Baerveldt glaucoma implant (model 101-350). Baseline and follow-up data were obtained on a per patient level and pooled. The associations between baseline risk factors and chronic hypotony were explored using a Cox proportional hazards regression model. MAIN OUTCOME MEASURE: Chronic hypotony, defined as intraocular pressure (IOP) ≤ 5 mm Hg on 2 consecutive visits after 3 months, tube ligation, or implant removal for hypotony. RESULTS: The cumulative probability of chronic hypotony after tube shunt surgery was 4.1% (95% CI = 2.6%-6.1%) at 5 years. Reduction in visual acuity (VA) from baseline was observed in 15 patients (71%) at the time of hypotony diagnosis. Significant predictors of chronic hypotony in multivariable analysis included randomized treatment (for Baerveldt glaucoma implant; HR = 5.12; 95% CI = 1.51-17.43; P = .009), uveitic glaucoma (HR = 3.75; 95% CI = 1.26-11.15; P = .017), and preoperative VA (per logMAR unit increase; HR = 1.55; 95% CI = 1.04-2.32; P = .031). CONCLUSIONS: Chronic hypotony is an uncommon complication of tube shunt surgery that usually produces a reduction in VA. Baseline factors associated with this complication are Baerveldt implantation, uveitic glaucoma, and poor VA. This study analyzes the largest prospectively collected dataset to date on tube shunt surgery.
引用
- Gedde AY, Huertas L, O'Brien R, et al. Chronic Hypotony After Tube Shunt Surgery: A Pooled Analysis of Data From Three Randomized Clinical Trials. Am J Ophthalmol. 2025. PMID: 41271024. doi:10.1016/j.ajo.2025.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。